APUS
Apimeds Pharmaceuticals US Inc.

296
Mkt Cap
$21.81M
Volume
36,842.00
52W High
$4.00
52W Low
$1.37
PE Ratio
-5.50
APUS Fundamentals
Price
$1.73
Prev Close
$1.80
Open
$1.81
50D MA
$1.87
Beta
0.64
Avg. Volume
112,592.43
EPS (Annual)
-$0.1188
P/B
2.24
Rev/Employee
$0.00
Loading...
Loading...
News
all
press releases
News Placeholder
Apimeds Pharmaceuticals says I love my Ducks with new ai Futures Lab Program collaboration with the University of Oregons Lundquist College of Business
Apimeds Pharmaceuticals US, Inc. (NYSE: APUS) (Apimeds) today announced the expansion of the Apimeds ai Futures Lab program through a new collaboration with the University of Oregons Lundquist...
Business Wire·10d ago

Latest APUS News

View

Advertisement|Remove ads.

Advertisement|Remove ads.